Charles Michaud Jr - Jan 3, 2024 Form 4 Insider Report for Homology Medicines, Inc. (FIXX)

Role: Vice President, Corporate Controller and Treasurer
Signature: /s/ Paul Alloway, Attorney-in-Fact for Charles Michaud, Jr.
Stock symbol: FIXX
Transactions as of: Jan 3, 2024
Transactions value $: -$975
Form type: 4
Date filed: 1/5/2024, 05:49 PM
Previous filing: Jan 3, 2024
Next filing: Mar 27, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FIXX	Common Stock	Sale	-$975	-1.71K	-12.84%	$0.57	11.6K	Jan 3, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units.
F2	The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.571 to $0.584. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2.

Remarks:

Vice President, Corporate Controller and Treasurer